As part of the 2023 edition of the Peptide Therapeutics Forum 2023, taking place as a hybrid conference in Basel and online, the SCS also offered the opportunity for students to present a contributed talk and honored the best contributions with the ‘Helvetica’ Best Contributed Talk Award. Dr. Richard Smith, Associate Editor of Chemistry Europe and Executive Editor of Helvetica, handed over the certificates and a cash contribution of CHF100 to the happy winners:

Mirja Harms, Ulm University Medical Center
«Preclinical development of the endogenous CXCR4 antagonist EPI-X4 for therapy of cancer and inflammatory diseases»

Héloïse Bürgisser, University of Zurich
«Chemical synthesis of c-Myc transactivation domain using a synthesis/solubility tag»

The abstracts of the short talks and additional information about the event are available for free on the website of the symposium on

Thanks to Helvetica Chimica Acta for sponsoring the event and for supporting the Best Contributed Talk Award Program. 

Céline Wittwer, SCS